Journal
BIOLOGICAL PSYCHIATRY
Volume 89, Issue 5, Pages 451-462Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.biopsych.2020.09.025
Keywords
-
Categories
Funding
- Autism Speaks [7567]
- Johnson Foundation
- Brain Foundation
- Genome, Environment, Microbiome, and Metabolome in Autism [825033]
- Axial Biotherapeutics
- National Institutes of Health [HD090214, MH100556]
Ask authors/readers for more resources
The study used mass spectrometry methods to identify metabolic differences between children with ASD and typically developing children. The findings indicated differences in amino acid, lipid, and xenobiotic metabolism, implicating oxidative stress, mitochondrial dysfunction, hormone level elevations, lipid profile changes, and altered levels of phenolic microbial metabolites. These results suggest a link between metabolism, gastrointestinal physiology, and complex behavioral traits in ASD.
BACKGROUND: Autism spectrum disorder (ASD) is a neurodevelopmental condition with hallmark behavioral manifestations including impaired social communication and restricted repetitive behavior. In addition, many affected individuals display metabolic imbalances, immune dysregulation, gastrointestinal dysfunction, and altered gut microbiome compositions. METHODS: We sought to better understand nonbehavioral features of ASD by determining molecular signatures in peripheral tissues through mass spectrometry methods (ultrahigh performance liquid chromatography-tandem mass spectrometry) with broad panels of identified metabolites. Herein, we compared the global metabolome of 231 plasma and 97 fecal samples from a large cohort of children with ASD and typically developing control children. RESULTS: Differences in amino acid, lipid, and xenobiotic metabolism distinguished ASD and typically developing samples. Our results implicated oxidative stress and mitochondrial dysfunction, hormone level elevations, lipid profile changes, and altered levels of phenolic microbial metabolites. We also revealed correlations between specific metabolite profiles and clinical behavior scores. Furthermore, a summary of metabolites modestly associated with gastrointestinal dysfunction in ASD is provided, and a pilot study of metabolites that can be transferred via fecal microbial transplant into mice is identified. CONCLUSIONS: These findings support a connection between metabolism, gastrointestinal physiology, and complex behavioral traits and may advance discovery and development of molecular biomarkers for ASD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available